Disparity in infection control practices for multidrug-resistant Enterobacteriaceae - 30/10/12
Toronto ESBL Working Group
Address correspondence to Matthew P. Muller, PhD, MD, St. Michael’s Hospital, 30 Bond Street, 4CC-North, Room 4-178, Toronto, ON, M5B 1W8, Canada.Abstract |
Background |
There is a lack of empiric evidence regarding the optimal approach to controlling the transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE). In this context, we expect that infection control practices for these organisms vary widely between hospitals.
Methods |
A survey examining infection control practices for ESBL-E and CRE was distributed to 6 academic and 9 community hospitals in Toronto, Canada.
Results |
All hospitals responded to the survey. Among 15 hospitals in 1 geographic area, 8 different approaches to the management of ESBL-E were utilized. There was wide variation in the use infection control practices including admission screening (53% and 53%), contact precautions (53% and 100%), and isolation (60% and 100%) for ESBL-E and CRE, respectively. Of hospitals performing admission screening, 75% used risk factor-based screening for ESBL-E and CRE.
Conclusion |
Even within a single geographic area, there is wide variation in infection control strategies to contain or control ESBL-E and CRE. These results are concerning given evidence that a coordinated approach may be required to prevent or limit the emergence of CRE.
Le texte complet de cet article est disponible en PDF.Key Words : Extended-spectrum β-lactamase-producing Enterobacteriaceae, ESBL, Carbapenem-resistant Enterobacteriaceae, CRE, Admission screening
Plan
| Members of the Toronto ESBL Working Group: Brigette Boaretto (Southlake Regional Health Centre), Sheila Churilla (Markham-Stouffville Hospital), Janine Domingos (William Osler Health Centre), Shasta Gibson (Credit Valley Hospital), Dr Susy Hota (University Health Network), Judy McCarten (Lakeridge Health), Christine Moore (Mount Sinai Hospital), Vydia Nankoosingh (The Scarborough Hospital), Dr Daniel Ricciuto (Lakeridge Health), Dr David Richardson (William Osler Health Centre), Dr Valerie Sales (Markham-Stouffville Hospital), Dr Alicia Sarabia (Credit Valley Hospital), Dr Michael Silverman (Lakeridge Health), Dr Andrew Simor (Sunnybrook Health Sciences Centre), Arla Tomiczek (Toronto East General Hospital). |
|
| Conflicts of interest: None to report. |
Vol 40 - N° 9
P. 836-839 - novembre 2012 Retour au numéro
Article précédent
- “Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa
- Dror Marchaim, Federico Perez, Jiha Lee, Suchitha Bheemreddy, Andrea M. Hujer, Susan Rudin, Kayoko Hayakawa, Paul R. Lephart, Christopher Blunden, Maryann Shango, Michelle L. Campbell, Jastin Varkey, Palaniappan Manickam, Diixa Patel, Jason M. Pogue, Teena Chopra, Emily T. Martin, Sorabh Dhar, Robert A. Bonomo, Keith S. Kaye
- Antibiotic use in Vietnamese hospitals: A multicenter point-prevalence study
- Truong Anh Thu, Mahbubur Rahman, Susan Coffin, Md. Harun-Or-Rashid, Junichi Sakamoto, Nguyen Viet Hung
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?